Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. The multi-year agreement will allow BMS to scale AI-powered workflows across trial design, ...

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has given ...

I’m already loving this device, and I haven’t even touched one. Arduino announced it has collaborated with M5Stack to develop the new compact and powerful Nesso N1 IoT development kit. This system ...

MicroPython is a well-known and easy-to-use way to program microcontrollers in Python. If you’re using an Arduino Uno Q, though, you’re stuck without it. [Natasha] saves the day by bringing us a a ...

When [OGS Mechanics] got a Mercedes EQC 300 battery-electric car in for repair, it was found to have a bit of a weird issue: ...

The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the end of an era. Medarex is one of the last independent public biotech companies that built their businesses around ...